Current Liabilities
Accrued Contingent Liabilities
Medtronic Accrued Contingent Liabilities remained flat by 0.0% to $200M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $200M to $200M. Over 4 years (FY 2021 to FY 2025), Accrued Contingent Liabilities shows relatively stable performance with a 0.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2015
Last reportedQ3 2026Feb 24, 2026
Metric ID:
accrued_contingent_liabilitiesHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $400M | $300M | $300M | $300M | $300M | $300M | $300M | $300M | $300M | $300M | $300M | $200M | $200M | $300M | $200M | $200M | $400M | $200M | $200M | $200M |
| QoQ Change | — | -25.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -33.3% | +0.0% | +50.0% | -33.3% | +0.0% | +100.0% | -50.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -25.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -33.3% | -33.3% | +0.0% | -33.3% | +0.0% | +100.0% | -33.3% | +0.0% | +0.0% |
Range$200M – $400M
CAGR-13.6%
Avg YoY Growth-3.6%
Median YoY Growth+0.0%
Current Streak2 quarters growth
Accrued Contingent Liabilities at Other Companies
Frequently Asked Questions
- What is Medtronic's accrued contingent liabilities?
- Medtronic (MDT) reported accrued contingent liabilities of $200M in Q4 2025.
- How has Medtronic's accrued contingent liabilities changed year-over-year?
- Medtronic's accrued contingent liabilities decreased by 0.0% year-over-year, from $200M to $200M.
- What is the long-term trend for Medtronic's accrued contingent liabilities?
- Over 4 years (2021 to 2025), Medtronic's accrued contingent liabilities has grown at a 0.0% compound annual growth rate (CAGR), from $400M to $400M.